Dobutamine Echocardiography In Patients With Ischemic Heart Failure Evaluated for Revascularization
Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
To define the role of the assessment of myocardial viability with dobutamine echocardiography
(DE) in the clinical evaluation and selection of the best treatment for a high-risk subset of
patients with coronary artery disease.